EyePoint Pharmaceuticals SEC Filings http://investors.psivida.com/ EyePoint Pharmaceuticals SEC Filings en 4: Statement of changes in beneficial ownership of securities http://investors.psivida.com/sec-filings/sec-filing/4/0001562180-19-003509 EyePoint Pharmaceuticals, Inc. Wed, 12 Jun 2019 16:42:29 -0400 EyePoint Pharmaceuticals SEC Filings 14051 3: Initial filing by director officer or owner of more than ten percent. http://investors.psivida.com/sec-filings/sec-filing/3/0001562180-19-003506 EyePoint Pharmaceuticals, Inc. Wed, 12 Jun 2019 16:38:28 -0400 EyePoint Pharmaceuticals SEC Filings 14046 8-K: Report of unscheduled material events or corporate event http://investors.psivida.com/sec-filings/sec-filing/8-k/0001193125-19-153328 EyePoint Pharmaceuticals, Inc. Wed, 22 May 2019 09:02:44 -0400 EyePoint Pharmaceuticals SEC Filings 14026 4: Statement of changes in beneficial ownership of securities http://investors.psivida.com/sec-filings/sec-filing/4/0001562180-19-002822 EyePoint Pharmaceuticals, Inc. Wed, 15 May 2019 17:23:13 -0400 EyePoint Pharmaceuticals SEC Filings 14021 10-Q: Quarterly report which provides a continuing view of a company's financial position http://investors.psivida.com/sec-filings/sec-filing/10-q/0001193125-19-144237 EyePoint Pharmaceuticals, Inc. Fri, 10 May 2019 16:13:49 -0400 EyePoint Pharmaceuticals SEC Filings 14001 8-K: Report of unscheduled material events or corporate event http://investors.psivida.com/sec-filings/sec-filing/8-k/0001193125-19-140432 EyePoint Pharmaceuticals, Inc. Wed, 08 May 2019 07:03:46 -0400 EyePoint Pharmaceuticals SEC Filings 13986 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") http://investors.psivida.com/sec-filings/sec-filing/def-14a/0001193125-19-125776 EyePoint Pharmaceuticals, Inc. Mon, 29 Apr 2019 17:37:19 -0400 EyePoint Pharmaceuticals SEC Filings 13971 DEFA14A: Additional proxy soliciting materials - definitive http://investors.psivida.com/sec-filings/sec-filing/defa14a/0001193125-19-125782 EyePoint Pharmaceuticals, Inc. Mon, 29 Apr 2019 17:37:18 -0400 EyePoint Pharmaceuticals SEC Filings 13966 8-K: Report of unscheduled material events or corporate event http://investors.psivida.com/sec-filings/sec-filing/8-k/0001193125-19-121055 EyePoint Pharmaceuticals, Inc. Fri, 26 Apr 2019 08:52:39 -0400 EyePoint Pharmaceuticals SEC Filings 13961 4: Statement of changes in beneficial ownership of securities http://investors.psivida.com/sec-filings/sec-filing/4/0001562180-19-002284 EyePoint Pharmaceuticals, Inc. Tue, 16 Apr 2019 08:20:22 -0400 EyePoint Pharmaceuticals SEC Filings 13946